You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DLI

Showing 1 - 25 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 15, 2023

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

Withdrawn
  • Leukemia
  • Stem Cell Transplantation
  • Munich, Bavaria, Germany
    3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)

Recruiting
  • Relapsed Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 7, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell

Not yet recruiting
  • Hematologic Malignancy
  • Haplo-identical Stem Cell Transplantation
  • CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
  • (no location specified)
Oct 1, 2021

Lens Dysfunction Index in Timing of Age-related Cataract Surgery

Recruiting
  • Age-Related Cataract
  • measure the preoperative DLI、 SS-OCT image of the lens,、take photos of the anterior segment and self-scoring of the preoperative visual quality assessment scale.
  • Hangzhou, Zhejiang, China
    Wenzhou Medical University
Jan 13, 2021

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

Chronic GVHD Trial in Bologna (T reg DLI)

Recruiting
  • Chronic Graft Versus Host Disease
  • T reg DLI
  • Bologna, BO, Italy
    University Hospital St. Orsola-Malpighi Polyclinic
Jan 14, 2021

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Durham (Idarubicin, Cytarabine, DLI)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Durham, North Carolina
    Duke University Medical Center
Dec 1, 2020

Hematological Malignancies, Regulatory T Cell Depletion, Relapse Trial in Creteil (T-reg depleted DLI, Standard DLI)

Recruiting
  • Hematological Malignancies
  • +2 more
  • T-reg depleted DLI
  • Standard DLI
  • Creteil, France
    Henri Mondor Hospital
Nov 19, 2020

Severe Combined Immunodeficiency Trial in Memphis (drug, device, other)

Recruiting
  • Severe Combined Immunodeficiency
  • Anti-thymocyte globulin (rabbit)
  • +5 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 6, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Total-Body Irradiation
  • +5 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022

Leukemia Trial in Badalona, Hospitalet de Llobregat, Barcelona (DLI of the 20 fraction of the UCBT)

Completed
  • Leukemia
  • DLI of the 20 fraction of the UCBT
  • Badalona, Barcelona, Spain
  • +4 more
Dec 3, 2021

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

Terminated
  • Chronic Myelogenous Leukemia
  • +7 more
  • CD3/CD28 Activated T cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 12, 2020

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)

Withdrawn
  • Acute Myeloid Leukemia
  • +7 more
  • MDG1021 dose 1
  • +3 more
  • Leiden, Zuid Holland, Netherlands
    Leiden University Medical Centre
Sep 30, 2021

Leukemia, Lymphoma Trial in Houston (HSCT, DLI)

Completed
  • Leukemia
  • Lymphoma
  • HSCT
  • DLI
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 9, 2021

Leukemia Trial in Philadelphia (Interferon alpha-2B (IFN-a) 3 million units (MU) subcutaneous daily)

Completed
  • Leukemia
  • Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 20, 2020